Enhanced Macrophage Uptake of Spray-Dried Phosphatidylserine-Loaded Microparticles for Pulmonary Drug Delivery

Matthew T Freeman1, Arianne Parvaresh-Rizi2, Samantha A Meenach1,3

  • 1Department of Chemical Engineering, University of Rhode Island, Kingston, RI 02881 USA.

Insights

This study developed inhalable microparticles (MPs) for targeted drug delivery to alveolar macrophages. The MPs enhance drug uptake by macrophages, improving treatments for macrophage-associated diseases.

Area of Science:

  • Immunology
  • Nanotechnology
  • Drug Delivery

Background:

  • Macrophages are crucial for innate immunity but can harbor pathogens like SARS-CoV-2.
  • Current treatments for macrophage-associated diseases often require systemic delivery, leading to inefficiencies.
  • Targeted drug delivery to macrophages offers a promising therapeutic strategy.

Purpose of the Study:

  • To develop an inhalable dry powder microparticle (MP) formulation for targeted drug delivery to alveolar macrophages.
  • To achieve controlled release of therapeutics within macrophages.
  • To overcome limitations of conventional systemic drug delivery methods.

Main Methods:

  • Synthesized acetalated dextran (Ac-Dex) MPs using a one-step spray drying method.
  • Loaded MPs with curcumin (model therapeutic) and 1,2-dipalmitoyl-sn-glycero-3-phospho-L-serine (DPPS) to enhance macrophage uptake.
  • Evaluated MP uptake by RAW 264.7 macrophages and assessed pH-responsive drug release and aerosolization properties.

Main Results:

  • DPPS-loaded MPs showed significantly enhanced and macrophage-specific uptake compared to control MPs.
  • The microparticles demonstrated pH-responsive drug release.
  • In vitro aerosol dispersion analysis confirmed the potential for effective pulmonary delivery.

Conclusions:

  • The developed inhalable MPs demonstrate potential for targeted delivery and controlled release of therapeutics to alveolar macrophages.
  • DPPS-mediated uptake enhances therapeutic efficacy for macrophage-associated diseases.
  • This formulation offers a promising approach to improve treatment outcomes for pulmonary infections and inflammatory conditions.

Related Concept Videos

Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Factors Affecting Dissolution: Particle Size and Effective Surface Area01:23

Factors Affecting Dissolution: Particle Size and Effective Surface Area

Dissolution kinetics, an essential aspect of oral drug delivery, is significantly influenced by the drug's particle size. According to the Noyes-Whitney dissolution model, the dissolution rate correlates directly with the drug's surface area. The larger the surface area, the higher the drug's solubility in water, leading to a faster drug dissolution rate. Reducing particle size increases the effective surface area, enhancing the dissolution process. Micronization and nanosizing are employed to...
Bioavailability Enhancement: Drug Permeability Enhancement01:27

Bioavailability Enhancement: Drug Permeability Enhancement

After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...